Adding stereotactic ablative radiotherapy (SAbR) to neoadjuvant chemotherapy improves pathologic outcomes for patients ...

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a study published online in the July issue of The Lancet Oncology.

Researchers have found in a recent study that weight loss and lowering blood sugar levels lower significantly the all-cause ...

Every Cruyff turn is a footprint. Some players leave lasting impressions; others barely register. Was peak Eden Hazard the ...

The National Cancer Institute and University of Oxford report that oral contraceptive use is not associated with increased ...

Tumor necrosis factor (TNF) inhibitor therapy was effective in reducing the likelihood that psoriasis would progress to ...

A new study shows young adults with higher exposure to atherogenic lipoprotein particles may be at a greater risk of ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

A secondary analysis of a large trial shows that exposure to the HIV drug abacavir is linked to an elevated risk for major ...

Breast cancer patients may have inferior recurrence-free survival after neoadjuvant chemotherapy if they are overweight or obese at diagnosis.

A comprehensive meta-analysis of over 4.3 million adults shows e-cigarette use is associated with significantly higher odds ...